MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    People with Parkinson’s Disease (PPD): disease, stigma and the others

    M. Bacigalupe (La Plata, Argentina)

    Objective: To show what does it mean to be PPD and the relationship with their environment from the point of view of the participants. Background:…
  • 2019 International Congress

    Complex disease burden in Parkinson’s and Advance Care Planning

    M. Khwaja, A. Chatterjee, G. Alg, A. Cotton, L. Richardson, H. Avery (Reading, United Kingdom)

    Objective: To evaluate if Advanced Care Planning is completed in patients with complex stage of Parkinson’s Disease (PD). Background: NICE (National Institute of Health and…
  • 2019 International Congress

    Difference in perception of the wearing-off between patients and physicians in Parkinson’s disease

    Y. Tsuboi, R. Nakagawa, M. Ishido, Y. Yoshinaga, T. Hashimoto, T. Mishima, S. Fujioka (Fukuoka, Japan)

    Objective: To explore if any inconsistency exists in the perception of the presence of wearing-off (WO) symptoms between patients and physicians in Parkinson’s disease (PD).…
  • 2019 International Congress

    Classification of Neurorehabilitation treatments: Preliminary results of a Multicentre Italian Study

    T. Bowman, F. Mestanza Mattos, R. Russo, M. Boninsegna, F. Marazzini, A. Marianelli, E. Pelosin, M. Putzolu, C. Cosentino, M. Petrarca, F. Tirinelli, M. Tondinelli, F. Trecate, M. Budel, A. Turolla, M. Agostini, D. Munari, P. Pillastrini, M. Branchini, D. Lunedei, G. Sgubin, D. Cattaneo, S. Mezzarobba (Milano, Italy)

    Objective: To taxonomize the contents of neurorehabilitation programs and categorize goals and treatments provided to people with Parkinson Disease(PD) and Multiple Sclerosis(MS) to understand their…
  • 2019 International Congress

    Prospective observational study to follow up a cohort of Parkinson’s outpatients during a 4-week rehabilitation

    E. Leblong, AL. Roy, B. Fraudet, A. Riou, E. Ceze, A. Rouxel, B. Nicolas, P. Gallien (Rennes, France)

    Objective: To evaluate the effectiveness of a 4-week program in a rehabilitation center for reconditioning and exercise on balance, walking and upper limb bradykinesia in…
  • 2019 International Congress

    The effectiveness of two-weeks self-stretch based on post-isometric relaxation in Parkinson’s disease patients

    A. Zimin, D. Yusupova (Moscow, Russian Federation)

    Objective: To estimate the influence of two weeks of PIR training performed by inpatients autonomously on their joints mobility and balance. Background: One of the…
  • 2019 International Congress

    Movement disorders as a clinical feature of Subacute Sclerosing Pan Encephalitis: Expansion of phenotypic spectrum

    D. Dash, M. Tripathi, R. Singh (Delhi, India)

    Objective: To study the frequency of movement Disorders(MD) in patients with Subacute Sclerosing Pan Encephalitis (SSPE). To describe the various type of MD in patients with…
  • 2019 International Congress

    Parkinson’s disease in Middle East, North Africa and South Asia: Consensus from the MDS Task Force on the Middle East

    H. Khalil, L. Chahine, J. Junaid Siddiqui, M. Salari, S. El-Jaafary, Z. Aldaajani, M. Abu Al-Melh, T. Mohammad, M. Abu Snineh, N. Syed, M. Bhatt, M. Habib, M. Habahbeh, S. Tabbal, B. Jeon, J. Bajwa (Irbid, Jordan)

    Objective: To create a list of needs and priorities in the advancement of the Movement Disorders field in general and Parkinson’s disease care in specific…
  • 2019 International Congress

    Wearable versus marker-free technologies: does it matter for clinical gait analysis?

    K. Otte, D. Drebinger, H. Röhling, T. Vater, D. Kroneberg, M. Voigt, B. Kayser, S. Mansow-Model, AU. Brandt, F. Paul, A. Lipp, T. Schmitz-Hübsch (Berlin, Germany)

    Objective: To compare wearable sensor-based and marker-less 3D video-based gait analysis in two neurodegenerative disorders associated with gait dysfunction. Background: Quantitative gait analysis supports diagnosis…
  • 2019 International Congress

    Effect of Medication Review on Reported Symptoms in Parkinson’s disease Patients

    C. Stuijt, T. Laar (Groningen, Netherlands)

    Objective: The objective was to analyse the effect of structured medication reviews (MR) in ambulatory PD patients on patient reported outcome measures (PROMS). Background: Patients…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 217
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley